Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             96 results found
no title author magazine year volume issue page(s) type
1 66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS Muscarella, L.A.
 2010
 36 S3 p. S114-
1 p.
 article
2 75 A COMPLEMENTARY TREATMENT IN BREAST CANCER IN-PATIENTS Lagattolla, F.
 2010
 36 S3 p. S117-
1 p.
 article
3 48 ACTIVATING MUTATION OF KRAS ONCOGENE AS A PREDICTIVE BIOMARKER OF RESPONSE TO FIRST-LINE CONVENTIONAL CHEMOTHERAPY: A RETROSPECTIVE ANALYSIS Strippoli, A.
 2010
 36 S3 p. S109-
1 p.
 article
4 22 ADHERENCE TO AND PERSISTENCE WITH AN ORAL METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS Mazzoni, E.
 2010
 36 S3 p. S101-
1 p.
 article
5 Adjuvant colon cancer chemotherapy: where we are and where we'll go Lombardi, L.
 2010
 36 S3 p. S34-S41
8 p.
 article
6 13 ADJUVANT RADIOCHEMOTHERAPY TREATMENT IN PATIENTS WITH GASTRIC CANCER Santoro, M.
 2010
 36 S3 p. S98-S99
2 p.
 article
7 63 A GROUP INTERVENTION IN CANCER INPATIENTS TROUGH MUSIC THERAPY Lagattolla, F.
 2010
 36 S3 p. S113-
1 p.
 article
8 44 A miRNA EXPRESSION PROFILING IDENTIFIES MIR-145 AS A KEY PLAYER IN HUMAN MALIGNANT PLEURAL MESOTHELIOMA Mattioli, E.
 2010
 36 S3 p. S108-
1 p.
 article
9 42 ANALYSIS OF MOLECULAR MECHANISMS AND ANTI-TUMORAL EFFECTS OF ZOLEDRONIC ACID IN BREAST CANCER CELLS Insalaco, L.
 2010
 36 S3 p. S107-
1 p.
 article
10 77 ANGIOGENESIS IN INDOLENT NON-HODGKIN'S LYMPHOMA (NHL) Minoia, C.
 2010
 36 S3 p. S117-S118
2 p.
 article
11 2 A NON COMMON BRAF MUTATION, c.1799-1801delTGA, IDENTIFIED IN SPORADIC COLORECTAL CANCER OF SICILIAN PATIENT Bruno, L.
 2010
 36 S3 p. S95-
1 p.
 article
12 38 ANTIANGIOGENIC PROPERTIES OF IMMUNOMODULATORY DRUG LENALIDOMIDE IN ENDOTHELIAL CELLS OF PATIENTS WITH ACTIVE MULTIPLE MYELOMA De Luisi, A.
 2010
 36 S3 p. S106-
1 p.
 article
13 Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer Guarneri, V.
 2010
 36 S3 p. S62-S66
5 p.
 article
14 7 A PATIENT WITH UNRESECTABLE ADVACED PANCREATIC CANCER ACHIEVING LONG-TERM SURVIVAL WITH GEMCITABINE-BASED CHEMOTHERAPY Lotesoriere, C.
 2010
 36 S3 p. S97-
1 p.
 article
15 15 A RETROSPECTIVE ANALYSIS OF CONTINUING ANDROGEN DEPRIVATION IN HORMONE-REFRACTORY PROSTATE CANCER Calvani, N.
 2010
 36 S3 p. S99-
1 p.
 article
16 14 A RETROSPECTIVE ANALYSIS OF SEQUENTIAL USE OF THE TYROSINE KINASE INHIBITORS (TKI) SORAFENIB (SOR) AND SUNITINIB (SUN) IN METASTATIC RENAL CELL CARCINOMA (mRCC) Calvani, N.
 2010
 36 S3 p. S99-
1 p.
 article
17 Author index 2010
 36 S3 p. S121-S123
3 p.
 article
18 34 AZD1152 PLUS GEMCITABINE FOR PANCREAS CANCER TREATMENT: IN VITRO AND IN VIVO STUDY Azzariti, A.
 2010
 36 S3 p. S105-
1 p.
 article
19 26 BIOLOGICAL AND PATHOLOGICAL CHARACTERIZATION OF INVASIVE BREAST CANCER WITH CHROMOSOME 17 (Ch17) ANEUSOMY Petroni, S.
 2010
 36 S3 p. S102-
1 p.
 article
20 47 BIOLOGICAL CHARACTERIZATION OF MC70, AS POTENT INHIBITOR OF ABC TRANSPORTERS INVOLVED IN MULTIDRUG RESISTANCE Quatrale, A.E.
 2010
 36 S3 p. S109-
1 p.
 article
21 Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas Fazio, Nicola
 2010
 36 S3 p. S87-S94
8 p.
 article
22 28 BREAST CANCER TISSUE TRYPTASE EXPRESSION AS A NEW POSSIBLE ANTIANGIOGENETIC TARGET Ranieri, G.
 2010
 36 S3 p. S103-
1 p.
 article
23 73 CANCER AT OTHER SITES THAN BREAST AND OVARY IN FAMILIES WITH OR WITHOUT BRCA1/2 GENES MUTATION Bruno, M.
 2010
 36 S3 p. S116-
1 p.
 article
24 10 CHEMORADIATION THERAPY FOR CARCINOMA OF THE ANAL CANAL Morelli, F.
 2010
 36 S3 p. S97-S98
2 p.
 article
25 16 CHOLINE PET BASED DOSE ESCALATION IN PROSTATE CANCER: DEFINITION OF DIVERSIFIED TARGET Santoro, M.
 2010
 36 S3 p. S99-
1 p.
 article
26 56 CISPLATIN VERSUS CARBOPLATIN-BASED REGIMENS IN THE FIRST-LINE TREATMENT OF SMALL CELL LUNG CANCER (SCLC): META-ANALYSIS OF PUBLISHED RANDOMIZED CLINICAL TRIALS (RCTS) Rossi, A.
 2010
 36 S3 p. S111-S112
2 p.
 article
27 6 C-KIT MUTATIONS IN GASTROINTESTINAL STROMAL TUMORS La Paglia, L.
 2010
 36 S3 p. S96-
1 p.
 article
28 43 CLINICAL SIGNIFICANCE OF INTRONIC VARIANTS OF BRCA GENES OF SICILIAN PATIENTS WITH HEREDITARY BREAST/OVARIAN CANCERS Margarese, N.
 2010
 36 S3 p. S107-S108
2 p.
 article
29 68 CONTRIBUTION OF THE FUNCTIONAL IMAGING IN THE RADIOTHERAPY TREATMENT PLANNING OF MALIGNANT GLIOMA: TO THE SEARCH OF THE TARGET AND REVISION OF THE LITERATURE Santoro, M.
 2010
 36 S3 p. S115-
1 p.
 article
30 41 COPY NUMBER VARIATION IN MALE BREAST CANCER Iannelli, G.
 2010
 36 S3 p. S107-
1 p.
 article
31 3 CORRELATION BETWEEN IGF1R AND CMET EXPRESSION AND OUTCOME OF PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) TREATED WITH CETUXIMAB PLUS CHEMOTHERAPY Di Salvatore, M.
 2010
 36 S3 p. S95-S96
2 p.
 article
32 36 DETECTION OF KRAS MUTATIONS IN COLORECTAL CARCINOMA PATIENTS WITH AN INTEGRATED PCR/SEQUENCING AND REAL TIME PCR APPROACH Carotenuto, P.
 2010
 36 S3 p. S105-
1 p.
 article
33 35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. Barbano, R.
 2010
 36 S3 p. S105-
1 p.
 article
34 Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma Bronte, Giuseppe
 2010
 36 S3 p. S21-S29
9 p.
 article
35 21 DUCTAL CARCINOMA IN SITU OF BREAST: ANALYSIS OF 232 CASES Latiano, T.P.
 2010
 36 S3 p. S101-
1 p.
 article
36 1 ECHOCARDIOGRAPHIC MONITORING DURING ANTHRACYCLINE ADMINISTRATION IN PATIENTS WITH HODGKIN'S AND NON-HODGKIN'S LYMPHOMA: THE TEI-INDEX EVALUATION Oliva, S.
 2010
 36 S3 p. S95-
1 p.
 article
37 Editorial Board 2010
 36 S3 p. i-
1 p.
 article
38 33 EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE Amodeo, V.
 2010
 36 S3 p. S104-S105
2 p.
 article
39 49 EFFECTS OF PPARg AGONIST CIGLITAZONE ON VEGF EXPRESSION IN BREAST CANCER CELLS Terrasi, M.
 2010
 36 S3 p. S109-
1 p.
 article
40 54 EPIDEMIOLOGY OF THE NEUROENDOCRINE TUMORS DIAGNOSED IN THE CARDARELLI HOSPITAL: A RETRO-SPECTIVE SINGLE-INSTITUTION ANALYSIS OF 299 CASES Rizzo, M.
 2010
 36 S3 p. S111-
1 p.
 article
41 53 ERLOTINIB TREATMENT IN A PATIENT WITH BRAIN METASTASES BY NSCLC Montrone, M.
 2010
 36 S3 p. S110-S111
2 p.
 article
42 70 EVALUATION OF THE GOOD TARGET AND OF THE GOOD METHODIC OF RADIOTHERAPY IN THE TREATMENT OF THE TUMORS OF THE MAXILLARY SINUS Santoro, M.
 2010
 36 S3 p. S115-S116
2 p.
 article
43 58 EXPERIMENTAL PERSECTIVE, COGNITIVE STUDY OFPERCEPTION EVALUATION OF FATIGUE AND DEPRESSION AMONG CAREGIVERS, ONCOLOGICAL PATIENTS IN CHEMOTHERAPY AND ONCOLOGIST TEAM. EQUI- CAR STUDY 09 Barzelloni, M.L.
 2010
 36 S3 p. S112-
1 p.
 article
44 39 EXPRESSION ANALYSIS OF AURKA UNDER HYPOXIA IN BREAST CANCER CELL LINES Fanale, D.
 2010
 36 S3 p. S106-
1 p.
 article
45 17 FACTORS INFLUENCING SURVIVAL AND PROGNOSIS IN EARLY BREAST CARCINOMA (T1N0M0) D'Addetta, C.
 2010
 36 S3 p. S99-S100
2 p.
 article
46 29 FIRST LINE CHEMOTHERAPY WITH DOCETAXEL/GEMCITABINE/TRASTUZUMAB (GOIM 2611) IN PATIENT WITH ADVANCED BREAST CANCER HER-2 POS: A CASE REPORT OF EARLY AND PROLONGED RESPONSE Riccardi, F.
 2010
 36 S3 p. S103-
1 p.
 article
47 78 FIRST-LINE MODIFIED SCHEDULE OF GEMCITABINE INDUCES HIGH CLINICAL BENEFIT RATE WITHOUT SIGNIFICANT TOXICITY IN ELDERLY OR NOT ELDERLY ECOG PS 2 PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER Nacci, A.
 2010
 36 S3 p. S118-
1 p.
 article
48 51 GASTROINTESTINAL METASTASIS OF NSCLC: A CASE REPORT AND LITERATURE REVIEW Leo, S.
 2010
 36 S3 p. S110-
1 p.
 article
49 45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS Muscarella, L.A.
 2010
 36 S3 p. S108-
1 p.
 article
50 27 HER2/NEU OVEREXPRESSION IN pT1a OR pT1b, N0,M0 BREAST CANCER Petroni, S.
 2010
 36 S3 p. S103-
1 p.
 article
51 31 HIGH ACTIVITY OF SEQUENTIAL COMBINATION OF LOW DOSE CHEMO-MODULATING TEMOZOLOMIDE (TMZ) + FOTEMUSTINE (FM) IN METASTATIC MELANOMA (MM). A FEASIBILITY STUDY Guida, M.
 2010
 36 S3 p. S104-
1 p.
 article
52 Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target De Vita, F.
 2010
 36 S3 p. S11-S15
5 p.
 article
53 37 HYPOXIA INDUCES DECREASED EXPRESSION OF BRCA2 IN BREAST CANCER CELL LINES Corsini, L.R.
 2010
 36 S3 p. S105-S106
2 p.
 article
54 11 IDENTIFICATION OF THE MICRORNAS EXPRESSION PROFILE IN COLORECTAL CANCER PATIENTS AND CORRELATION WITH CLINICO-PATHOLOGICAL DATA Piepoli, A.
 2010
 36 S3 p. S98-
1 p.
 article
55 50 IMPLEMENTATION OF ADHERENCE TO ERLOTINIB (E) AS SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) Gebbia, V.
 2010
 36 S3 p. S110-
1 p.
 article
56 76 IMPROVING PATIENTS ACCEPTANCE OF TOTALLY IMPLANTED PORTS (TIP): THE EXPERIENCE OF A SINGLE INSTITUTION Marino, A.
 2010
 36 S3 p. S117-
1 p.
 article
57 12 IN SITU SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS-RELATED ANTIGENS IN HEPATOCELLULAR CARCINOMA Sansonno, L.
 2010
 36 S3 p. S98-
1 p.
 article
58 46 IS BCRP EXPRESSION AND LOCALIZATION REGULATED BY EGFR PATHWAY IN NSCLC CELLS? Porcelli, L.
 2010
 36 S3 p. S108-
1 p.
 article
59 72 KAPOSI'S SARCOMA TREATED CONTINUOUSLY FOR ABOUT THREE YEARS WITH WEEKLY AND BI-WEEKLY VINBLASTINE WITH GOOD DISEASE CONTROL: A CASE REPORT Rizzo, P.
 2010
 36 S3 p. S116-
1 p.
 article
60 Lapatinib in breast cancer: clinical experiences and future perspectives Giampaglia, M.
 2010
 36 S3 p. S72-S79
8 p.
 article
61 Maintenance or non-maintenance therapy in the treatment of advanced non-small cell lung cancer: that is the question Galetta, D.
 2010
 36 S3 p. S30-S33
4 p.
 article
62 Maintenance therapy in colon cancer Giuliani, F.
 2010
 36 S3 p. S42-S45
4 p.
 article
63 Molecularly targeted endocrine therapies for breast cancer Orlando, L.
 2010
 36 S3 p. S67-S71
5 p.
 article
64 20 NEOADJUVANT CHEMOTHERAPY OF BREAST CANCER: OUR EXPERIENCE Latiano, T.P.
 2010
 36 S3 p. S100-S101
2 p.
 article
65 New molecular targets in bone metastases Santini, D.
 2010
 36 S3 p. S6-S10
5 p.
 article
66 24 NEW PREOPERATIVE CHEMOTHERAPY WITH LYPOSOMAL ANTHRACYLINE, CISPLATIN AND METRONOMIC CAPECITABINE FOR OPERABLE AND LOCALLY ADVANCED BREAST CANCER: DATA OF EFFICACY AND SAFETY Orlando, L.
 2010
 36 S3 p. S102-
1 p.
 article
67 60 NURSES BURNOUT SYNDROME. AN ONCOLOGY UNIT SURVEY Fimiani, F.
 2010
 36 S3 p. S112-S113
2 p.
 article
68 67 OPTIMIZATION OF THE THERAPEUTIC RATIO IN CANCER THERAPY: THE INTERACTION BETWEEN DRUGS, MOLECULAR TARGETS AND RADIATIONS Santoro, M.
 2010
 36 S3 p. S114-S115
2 p.
 article
69 32 PAIN MANAGEMENT AND QUALITY LIFE IN BONE METASTASIS FROM BREAST CANCER: ROLE OF RADIOTHERAPY Santoro, M.
 2010
 36 S3 p. S104-
1 p.
 article
70 5 PANITUMUMAB PLUS CHEMOTHERAPY AS SALVAGE TREATMENT IN PRETREATED ADVANCED COLORECTAL CANCER PATIENTS: A SINGLE INSTITUTION'S EXPERIENCE Giuliani, F.
 2010
 36 S3 p. S96-
1 p.
 article
71 74 PHARMACOECONOMIC EVALUATION IN ONCOLOGY: ANALYSIS OF TWO HIGH IMPACT DISEASE Cigolari, S.
 2010
 36 S3 p. S116-S117
2 p.
 article
72 59 POST-TRAUMATIC GROWTH IN LONG TERM CANCER SURVIVORS Cormio, C.
 2010
 36 S3 p. S112-
1 p.
 article
73 71 PREVENTION, ASSESSMENT AND MANAGEMENT OF ORAL MUCOSITIS IN THE TREATMENT OF HEAD AND NECK CANCERS WITH RADIOTHERAPY OR RADIOCHEMOTHERAPY Santoro, M.
 2010
 36 S3 p. S116-
1 p.
 article
74 69 PRIMARY PROPHYLAXIS OF FEBRILE NEUTROPENIA BY LENOGRASTIM IN SARCOMA, BREAST AND LUNG CANCER PATIENTS TREATED WITH CHEMOTHERAPY Badalamenti, G.
 2010
 36 S3 p. S115-
1 p.
 article
75 65 PROGETTO A.M.O.R.E. – Assistenza Mirata Oncologica alla peRsona in trattamEnto Turaccio, M.
 2010
 36 S3 p. S114-
1 p.
 article
76 Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Rizzo, Sergio
 2010
 36 S3 p. S56-S61
6 p.
 article
77 30 RADIOTHERAPY IN THE SPINAL CORD COMPRESSION FOR METASTATIC BREAST CANCER: PAIN MANAGEMET AND QUALITY OF LIFE Santoro, M.
 2010
 36 S3 p. S103-S104
2 p.
 article
78 18 SAFETY AND EFFICACY OF LOW DOSE METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS Fedele, P.
 2010
 36 S3 p. S100-
1 p.
 article
79 4 SORAFENIB PLUS CISPLATIN AND GEMCITABINE IN THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA (HCC): A PHASE II STUDY BY THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE (PROT. GOIM 2705) Giuliani, F.
 2010
 36 S3 p. S96-
1 p.
 article
80 9 SQUAMOUS CELL CARCINOMA OF THE PENIS: A REPORT OF 20 CASES Morelli, F.
 2010
 36 S3 p. S97-
1 p.
 article
81 8 SURGERY AFTER HIGH DOSE CHEMOTHERAPY FOR POOR RISK NON SEMINOMATOUS GERM CELL TUMORS (GCTs): A LONG FOLLOW UP Morelli, F.
 2010
 36 S3 p. S97-
1 p.
 article
82 55 THE HIGH INCIDENCE OF LUNG CANCER IN A GENERAL HOSPITAL: A RETROSPECTIVE SINGLE-INSTITUTION ANALYSIS IN 2009 Rocco, D.
 2010
 36 S3 p. S111-
1 p.
 article
83 19 THE IMPORTANCE OF A CAREFUL CARDIOLOGIC FOLLOW UP IN BREAST CANCER SURVIVORS: PRELIMINARY DATA OF AN OBSERVATIONAL STUDY Galluci, G.
 2010
 36 S3 p. S100-
1 p.
 article
84 Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancer Sartore-Bianchi, A.
 2010
 36 S3 p. S1-S5
5 p.
 article
85 62 THE ROLE OF PSYCHOLOGICAL ASPECTS IN ONCOGENETIC COUNSELLING Foddai, E.
 2010
 36 S3 p. S113-
1 p.
 article
86 The therapy of kidney cancer with biomolecular drugs Di Lorenzo, G.
 2010
 36 S3 p. S16-S20
5 p.
 article
87 40 ThinPrepR CYTOLOGICAL SPECIMENS ARE OFTEN MORE SUITABLE THAN HISTOLOGICAL SPECIMENS TO DETECT EGFR AND K-RAS MUTATIONS IN NSCLC AND COLORECTAL CARCINOMA Galetta, D.
 2010
 36 S3 p. S106-S107
2 p.
 article
88 52 THIRD LINE TREATMENT WITH A MODIFIED SCHEDULE OF VINORELBINE IN ADVANCED NSCLC PATIENTS WITH A POOR ECOG PERFORMANCE STATUS Mazzoni, E.
 2010
 36 S3 p. S110-
1 p.
 article
89 25 TRASTUZUMAB TREATMENT IN PATIENT WITH BREAST CANCER AND METASTATIC CNS DISEASE Perrucci, B.
 2010
 36 S3 p. S102-
1 p.
 article
90 Treatment of triple negative breast cancer (TNBC): current options and future perspectives De Laurentiis, M.
 2010
 36 S3 p. S80-S86
7 p.
 article
91 Update on capecitabine alone and in combination regimens in colorectal cancer patients Silvestris, N.
 2010
 36 S3 p. S46-S55
10 p.
 article
92 79 VUS VARIANTS IN BRCA GENES OF HEREDITARY BREAST/OVARIAN CANCER Perez, M.
 2010
 36 S3 p. S118-S119
2 p.
 article
93 61 WELL-BEING, SOURCES OF STRESS AND COPING STRATEGIES IN A SAMPLE OF ONCOLOGISTS Foddai, E.
 2010
 36 S3 p. S113-
1 p.
 article
94 64 WHAT ABOUT WORKING AFTER CANCER? Romito, F.
 2010
 36 S3 p. S113-S114
2 p.
 article
95 57 WHAT TARGET IN THE TREATMENT OF OF NON-SMALL-CELL LUNG CANCER WITH THREE DIMENSIONAL CONFORMAL RADIOTHERAPY (3D-CRT): ELECTIVE NODAL IRRADIATION (ENI) OR NON-ELECTIVE NODAL IRRADIATION ? Santoro, M.
 2010
 36 S3 p. S112-
1 p.
 article
96 23 ZOLEDRONIC ACID BLOCKS THE INTERACTION BETWEEN MESENCHYMAL STEM CELLS AND BREAST CANCER CELLS Normanno, N.
 2010
 36 S3 p. S101-S102
2 p.
 article
                             96 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands